Original Research
Published on 14 Oct 2022
Economic burden of opioid misuse focused on direct medical costs
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.928890
- 3,284 views
- 1 citation
51 articles related to "Direct Medical Costs"
Articles
Original Research
Published on 09 May 2023
Direct medical costs of ischemic heart disease in urban Southern China: a 5-year retrospective analysis of an all-payer health claims database in Guangzhou City
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2023.1146914
- 2,975 views
- 4 citations
Original Research
Published on 10 Jun 2020
Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2020.00719
- 6,479 views
- 16 citations
Original Research
Published on 20 Jun 2022
Direct Medical Costs of Tetanus, Dengue, and Sepsis Patients in an Intensive Care Unit in Vietnam
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2022.893200
- 8,655 views
- 13 citations
Original Research
Published on 16 Jul 2025
Burden of respiratory syncytial virus disease in infants and the potential value of maternal immunization in Greece
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1611483
- 1,890 views
Original Research
Published on 28 Sep 2021
Risk of Cardiovascular Events and Medical Cost of Dapagliflozin and Dipeptidyl Peptidase-4 Inhibitors
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2021.689885
- 3,214 views
Original Research
Published on 07 Aug 2017
Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria
in Gastroenterology
Frontiers in Medicine
doi 10.3389/fmed.2017.00125
- 3,945 views
- 3 citations
Original Research
Published on 20 Oct 2022
Health economic burden of COVID-19 in Saudi Arabia
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2022.927494
- 10,712 views
- 9 citations
Original Research
Published on 20 Nov 2024
Cost-effectiveness analysis of tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma: perspectives from the United States and China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1461571
- 2,818 views
- 4 citations
Original Research
Accepted on 22 Sep 2025
Rising Direct Medical Costs of Osteoarthritis in Germany from 2002 to 2020: Trends, Demographic Drivers, and Public Health Considerations
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1627510
- 307 views
Original Research
Published on 24 Apr 2023
Retrospective content analysis of consumer product reviews related to chronic pain
in Health Informatics
Frontiers in Digital Health
doi 10.3389/fdgth.2023.958338
- 2,208 views
- 1 citation
Original Research
Published on 28 Mar 2025
How much can we reduce delivery-related medical costs associated with maternal mortality? A nationwide cohort study from 2003 to 2021
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1411534
- 1,352 views
Original Research
Published on 09 Dec 2021
The Cost-Effectiveness Analysis of Self-Efficacy-Focused Structured Education Program for Patients With Type 2 Diabetes Mellitus in Mainland China Setting
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2021.767123
- 6,098 views
- 10 citations
Original Research
Published on 04 Dec 2020
First-Line Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide for Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.602185
- 6,887 views
- 30 citations
Original Research
Published on 09 Aug 2023
Cost-effectiveness analysis of once-daily oral semaglutide versus placebo and subcutaneous glucagon-like peptide-1 receptor agonists added to insulin in patients with type 2 diabetes in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1226778
- 9,551 views
- 6 citations
Original Research
Published on 22 Apr 2024
Cost-effectiveness of additional serplulimab to chemotherapy in metastatic squamous non-small cell lung cancer patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1382088
- 2,655 views
- 1 citation